Security key
71880W501
Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)
CUSIP: 71880W501
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 100,618
- Total 13F value
- $130,801
- Share change
- -53,225
- SEC-reported price per share
- $1.30
- Number of holders
- 10
- Value change
- -$133,237
- Number of buys
- 7
- Number of sells
- 5
- Shares outstanding
- 12,067,869
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
10
Top holders
10
PHIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Phio Pharmaceuticals Corp. SEC filings
Phio Pharmaceuticals Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71880W501
Recent filing periods:
Ownership snapshot
Top reported holders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITADEL ADVISORS LLC
Disclosed value leader
Gerrit Dispersyn
Comparable rows
11/15
Latest evidence
31 Dec 2024
13F
3/4/5
Lead comparable stake: 0.37%
4 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CITADEL ADVISORS LLC leads the comparable SEC ownership view at 0.37%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITADEL ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
CITADEL ADVISORS LLC
0.37%
HRT FINANCIAL LP
0.35%
Virtu Financial LLC
0.34%
Cetera Investment Advisers
0.11%
MORGAN STANLEY
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
Company
|
0.37%
|
$80,147
44,526 shares
|
— | 31 Dec 2024 |
| HRT FINANCIAL LP |
13F
Company
|
0.35%
|
$76,000
42,338 shares
|
— | 31 Dec 2024 |
| Virtu Financial LLC |
13F
Company
|
0.34%
|
$74,000
40,910 shares
|
— | 31 Dec 2024 |
| Cetera Investment Advisers |
13F
Company
|
0.11%
|
$23,400
13,000 shares
|
— | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
0.05%
|
$10,640
5,911 shares
|
— | 31 Dec 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.04%
|
$8,428
4,682 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
100,618
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
24
Q1 2025 holders
10
Holder diff
-14
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend